trending Market Intelligence /marketintelligence/en/news-insights/trending/_oZQedgjUOuAGbCFGaL5Tw2 content esgSubNav
In This List

Immunotec fiscal Q2 profit falls YOY

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Volume of Investment Research Reports on Inflation Increased in Q4 2021


Immunotec fiscal Q2 profit falls YOY

Immunotec Inc. said its normalized net income for the fiscal second quarter ended April 30 was C$267,070, a fall of 61.4% from C$692,240 in the year-earlier period.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

The normalized profit margin fell to 1.3% from 3.6% in the year-earlier period.

Total revenue grew year over year to C$20.0 million from C$19.1 million, and total operating expenses climbed 5.1% from the prior-year period to C$18.7 million from C$17.8 million.

Reported net income decreased 53.2% year over year to C$323,180, or 0 cents per share, from C$690,680, or 1 cents per share.